Abacus FCF Advisors LLC bought a new position in Lam Research Corporation (NASDAQ:LRCX - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 45,031 shares of the semiconductor company's stock, valued at approximately $19,513,000. Lam Research makes up about 3.6% of Abacus FCF Advisors LLC's portfolio, making the stock its 4th biggest position.
Other institutional investors have also made changes to their positions in the company. Brighton Jones LLC lifted its holdings in shares of Lam Research by 1,032.4% in the 4th quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company's stock worth $1,025,000 after purchasing an additional 12,936 shares during the last quarter. Caxton Associates LLP bought a new position in Lam Research during the 1st quarter worth $239,000. Gabelli Funds LLC acquired a new stake in Lam Research in the second quarter worth $253,000. NewEdge Advisors LLC increased its position in Lam Research by 2.7% in the second quarter. NewEdge Advisors LLC now owns 100,528 shares of the semiconductor company's stock worth $9,785,000 after buying an additional 2,661 shares during the period. Finally, Osterweis Capital Management Inc. lifted its stake in Lam Research by 5,206.7% in the second quarter. Osterweis Capital Management Inc. now owns 796 shares of the semiconductor company's stock valued at $77,000 after buying an additional 781 shares during the last quarter. 84.61% of the stock is currently owned by institutional investors.
Lam Research Stock Performance
LRCX opened at $310.17 on Tuesday. The business has a 50 day moving average price of $335.90 and a two-hundred day moving average price of $286.99. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91. The company has a market capitalization of $388.12 billion, a price-to-earnings ratio of 53.85, a price-to-earnings-growth ratio of 1.25 and a beta of 1.84. Lam Research Corporation has a 1-year low of $94.11 and a 1-year high of $438.50.
Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The company had revenue of $6.72 billion for the quarter, compared to analysts' expectations of $6.66 billion. During the same period last year, the firm earned $1.33 EPS. The firm's revenue for the quarter was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Research analysts predict that Lam Research Corporation will post 9.32 EPS for the current fiscal year.
Analyst Ratings Changes
Several equities analysts have recently commented on the stock. HSBC restated a "hold" rating and set a $333.00 price target on shares of Lam Research in a research report on Monday, July 27th. Susquehanna reissued a "positive" rating and set a $475.00 target price (up from $385.00) on shares of Lam Research in a research note on Tuesday, June 30th. Barclays restated an "overweight" rating and issued a $335.00 target price (up from $275.00) on shares of Lam Research in a research report on Thursday, June 11th. New Street Research lifted their price target on Lam Research from $235.00 to $280.00 and gave the company a "neutral" rating in a report on Monday, April 27th. Finally, Zacks Research upgraded Lam Research from a "hold" rating to a "strong-buy" rating in a research report on Friday, July 17th. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $358.47.
View Our Latest Stock Report on Lam Research
Insider Buying and Selling
In related news, SVP Neil J. Fernandes sold 7,659 shares of Lam Research stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the transaction, the senior vice president directly owned 58,470 shares of the company's stock, valued at $18,102,312. The trade was a 11.58% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the business's stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the completion of the sale, the director owned 199,205 shares in the company, valued at approximately $69,881,114. This trade represents a 21.48% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 80,441 shares of company stock valued at $27,614,296 over the last three months. Company insiders own 0.31% of the company's stock.
Lam Research Company Profile
(
Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
